Complications_following_external_beam_radiation_therapy_for_prostate_cancer:_an_analysis_of_patients_treated_with_and_without_staging_pelvic_lymphadenectomy._We_reviewed_the_treatment_morbidity_associated_with_definitive_high_energy_external_beam_radiotherapy_in_289_consecutive_patients_with_clinically_localized_prostate_cancer_(stages_A2_to_C)_treated_from_1984_to_1988_inclusively._All_patients_were_treated_with_18_mv._photon_beams_via_a_4-field_box_technique._Radiation_doses_ranged_from_5,858_to_6,900_cGy.,_with_a_mean_dose_of_6,456_cGy._and_a_median_dose_of_6,400_cGy._A_total_of_65_patients_underwent_extraperitoneal_pelvic_staging_lymphadenectomy_before_radiotherapy._Complications_noted_in_42_patients_were_mild_(generally_trivial)_in_23_and_moderate_in_19_(6.6%)._There_were_no_severe_complications._The_actuarial_incidence_of_moderate_complications_was_9%_at_5_years._Only_6_patients_experienced_symptoms_for_longer_than_6_months._The_risk_of_complications_was_not_increased_in_patients_who_had_undergone_prior_lymph_node_dissection,_and_only_2_of_65_had_mild_lymphedema,_which_resolved_in_both_cases._We_conclude_that_high_energy_external_beam_radiation_for_prostate_cancer_can_be_delivered_with_a_low_risk_of_serious_complications,_even_in_patients_who_have_undergone_extraperitoneal_staging_pelvic_lymphadenectomy,_provided_the_patients_are_treated_to_limited_fields_with_high_energy_photons_and_at_doses_limited_to_6,800_cGy._or_less.